Tackling the lack of gender diversity in life sciences by turning the ‘Red Flags’ to ‘Green’
What is your post-IPO plan?
Has your board reached a critical mass?
Are you taking the right path?
Should you separate the role of CEO and Chair?
Why don’t you simply ask?